LEE PHARMA LTD

Overview

LEE PHARMA LTD is an active pharmaceutical ingredient (API) supplier with 57 active FDA Type II Drug Master Files, covering AMLODIPINE BESYLATE; APIXABAN; BEMPEDOIC ACID; BEPOTASTINE BESILATE; BILASTINE; BILASTINE FORM 1.

API / Drug Master Files

LEE PHARMA LTD holds 57 active (57 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• AMLODIPINE BESYLATEActive2026-02-20
• CENOBAMATEActive2026-01-12
• VIBEGRONActive2026-01-10
• BILASTINE FORM 1Active2025-11-28
• SUZETRIGINE ASDActive2025-09-08
• VERICIGUATActive2025-09-04
• ELUXADOLINEActive2025-09-04
• LENACAPAVIR SODIUMActive2025-08-06
• TICAGRELORActive2025-05-31
• RESMETIROM (LP FORM)Active2025-05-23
• LacosamideActive2025-05-21
• ITRACONAZOLE USPActive2025-03-17
• PANTOPRAZOLE SODIUMActive2025-02-10
• SACUBITRIL VALSARTAN SODIUM COMPLEXActive2025-02-10
• FINERENONEActive2025-02-01

Showing 15 of 57 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LEE PHARMA LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.